Chemours (CC) Other Accumulated Expenses (2015 - 2026)

Chemours has reported Other Accumulated Expenses for 12 years, with the latest figure at $153.0 million in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses fell 31.08% year-over-year to $153.0 million in Q2 2026; TTM through Jun 2026 was $153.0 million, a 31.08% decrease from a year earlier, with the FY2025 full-year figure at $150.0 million, up 30.43% from the prior year.
• Other Accumulated Expenses was $153.0 million for Q2 2026 at Chemours, up from $129.0 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $239.0 million in Q2 2022, with the low at $115.0 million in Q4 2024.
• Average Other Accumulated Expenses over 5 years is $159.7 million, with a median of $149.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 180.0% in 2022, then slumped 38.08% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $194.0 million in 2022, then declined by 23.71% to $148.0 million in 2023, then fell by 22.3% to $115.0 million in 2024, then surged by 30.43% to $150.0 million in 2025, then rose by 2.0% to $153.0 million in 2026.
• The last three Other Accumulated Expenses figures came in at $153.0 million (Q2 2026), $129.0 million (Q1 2026), and $150.0 million (Q4 2025), per Business Quant data.